Preview

FARMAKOEKONOMIKA. Modern Pharmacoeconomic and Pharmacoepidemiology

Advanced search

Developing clinical guidelines and assessing the quality of medical care using the RAND/UCLA method

https://doi.org/10.17749/2070-4909.2019.12.4.327-332

Full Text:

Abstract

Introduction. The RAND/UCLA system is commonly used in healthcare economics as it allows one to consider both the relevant scientific data and the opinion of leading experts for deciding on the specifics of medical care.

Objective. To analyze the recommendations and practical aspects of the RAND/UCLA and the international experience in using this method; to analyze the feasibility of its application in the Russian Federation, including the basic documents regulating the national medical care.

Materials and methods. We analyzed the information available in the RAND corporation website and the PubMed bibliographic database.

Results. An analysis of the original information provided by the developers of the RAND/UCLA method showed that using this method involves several stages: selecting a subject to be further studied, reviewing the scientific literature on this subject, choosing the expert commission, and preparing documents for its work; the voting stage is followed by a voting results analysis. The international experience on the applications of the RAND/UCLA method in healthcare demonstrates the successful use of this method in different countries. The use of the RAND/UCLA method in the healthcare system of the Russian Federation can contribute to improving the quality of medical care and the rational use of healthcare resources.

Discussion. Currently, the RAND/UCLA method is internationally used to develop clinical guidelines, criteria for assessing the quality of medical care, and feasibility of medical interventions.

Concusion. In the Russian Federation, the application of the RAND/UCLA method can prove useful for developing clinical guidelines and related documentation.

About the Authors

O. O. Buzuverova
Center for Healthcare Quality Assessment and Control of the Ministry of Healthcare of the Russian Federation
Russian Federation

Olga O. Buzuverova – Leading Specialist, Department of Medical Support for Standartization.

10-5 Khokhlovskii pereulok, Moscow 109028



V. K. Fedyaeva
Center for Healthcare Quality Assessment and Control of the Ministry of Healthcare of the Russian Federation; Financial Research Institute of the Ministry of Finance of the Russian Federation
Russian Federation

Vlada K. Fedyaeva – Deputy Head, Department of Medical Support for Standartization, Center for Healthcare Quality Assessment and Control of the Ministry of Health of the Russian Federation; Researcher, Laboratory of Health Technology Assessment at the Institute for Applied Economic Research of the Russian Presidential Academy of National Economy and Public Administration.

Scopus Author ID: 57189502826

10-5 Khokhlovskii pereulok, Moscow 109028

3-2 Nastasyinsky pereulok, Moscow 127006



O. A. Sukhorukikh
Center for Healthcare Quality Assessment and Control of the Ministry of Healthcare of the Russian Federation; Russian Presidential Academy of National Economy and Public Administration
Russian Federation

Olga A. Sukhorukikh – Head, Department of Medical Support for Standartization, Center for Healthcare Quality Assessment and Control of the Ministry of Health of the Russian Federation; Laboratory Assistant-Researcher, HealthCare Finance Center at the Research Financial Institute, Ministry of Finance of the Russian Federation.

Scopus Author ID: 57201486113

10-5 Khokhlovskii pereulok, Moscow 109028

82 Vernadskogo prospect, Moscow 119571



References

1. Lukyantseva D.V., Sukhorukikh O.A., Omelyanovsky V.V. Medical care of ambulatory patients and its assessment: a review of international experience. FARMAKOEKONOMIKA. Sovremennaya farmakoekonomika i farmakoepidemiologiya / FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology. 2018; 11 (1): 45-49. (In Russ.). https://doi.org/10.17749/2070-4909.2018.11.1.045-049.

2. Fitch K. et al. The RAND/UCLA appropriateness method user’s manual. Rand Corp Santa Monica CA. 2001; №. RAND/MR-1269-DGXII/RE.

3. Linstone H.A. et al. (ed.). The delphi method. Reading, MA. Addison-Wesley, 1975; 3-12.

4. Fink A. et al. Consensus methods: characteristics and guidelines for use. American journal of public health. 1984; 74 (9): 979-983.

5. Shea B.J., Grimshaw J.M., Wells G.A. et al. Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews. BMC Med Res Methodol. 2007 Feb 15; 7: 10. https://doi.org/10.1186/1471-2288-7-10.

6. Ringold S., Weiss P., Beukelman T., DeWitt E., Ilowite N., Kimura Y., Laxer R., Lovell D., Nigrovic P., Robinson A., Vehe R. 2013 Update of the 2011 American College of Rheumatology Recommendations for the Treatment of Juvenile Idiopathic Arthritis. Modern Rheumatology Journal. 2014; 8 (3): 9-22. https://doi.org/10.14412/1996-7012-2014-3-9-22

7. Sanders D.B. et al. International consensus guidance for management of myasthenia gravis: executive summary. Neurology. 2016; 87 (4): 419-425.

8. Daubs M.D. et al. How does sagittal imbalance affect the appropriateness of surgical indications and selection of procedure in the treatment of degenerative scoliosis? Findings from the RAND/UCLA Appropriate Use Criteria study. The Spine Journal. 2018; 18 (5): 900-911. https://doi.org/10.1016/j.spinee.2018.01.027.

9. Bennett S. et al. Ottawa criteria for appropriate transfusions in hepatectomy: using the RAND/UCLA appropriateness method. Annals of surgery. 2018; 267 (4): 766-774.

10. Saust L.T. et al. Quality indicators for the diagnosis and antibiotic treatment of acute respiratory tract infections in general practice: a RAND Appropriateness Method. Scandinavian journal of primary health care. 2017; 35 (2): 192-200.

11. Yajima N. et al. The development of quality indicators for systemic lupus erythematosus using electronic health data: A modified RAND appropriateness method. Modern rheumatology. 2019; 1-7.


For citation:


Buzuverova O.O., Fedyaeva V.K., Sukhorukikh O.A. Developing clinical guidelines and assessing the quality of medical care using the RAND/UCLA method. FARMAKOEKONOMIKA. Modern Pharmacoeconomic and Pharmacoepidemiology. 2019;12(4):327-332. (In Russ.) https://doi.org/10.17749/2070-4909.2019.12.4.327-332

Views: 177


ISSN 2070-4909 (Print)
ISSN 2070-4933 (Online)